11.04.25 -- Video Spotlight: Where Science Meets Magic with MIT Institute Professor Robert S. Langer

See a streamlined dPCR-based workflow for precise lentiviral vector quantification to support safer, more consistent cell and gene therapies through accurate genome titer, VCN, and RCL assessment.

To guide your decision-making process more effectively, we’ve outlined the top 10 criteria to consider when evaluating PDX models for your next oncology research or drug development program.

Testing for nitrosamines — potential carcinogens found in food, beverages, cosmetics, and pharmaceuticals — is essential in the development and manufacturing of APIs to ensure compliance.

Discover why formulation development is a critical, high-stakes process that plays a pivitol role in transforming scientific innovation into safe, effective, and accessible therapies for patients.

Uncover how precise flow cytometric identification of CAR+ cells across diverse models and workflows enables high specificity, flexibility, and sensitivity—even in rare or low-expression populations.

Nitrosamines pose a serious risk in drug products, driven by secondary amines, conducive conditions, and nitrosating agents. Understanding these factors is key to mitigating risk and ensuring patient safety.

Explore the power of discovery research, the key trends shaping the future of early-phase drug development, and gain insights from two exclusive case studies from our Sacramento facility.

Learn more about defining the spray drying process with an emphasis on specific enhancements to accommodate scale-up to commercial scale equipment of challenging applications or molecules.